J Cancer 2018; 9(8):1437-1447. doi:10.7150/jca.23969

Research Report

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

Naoto T. Ueno1✉*, Jose Rodrigo Espinosa Fernandez1*, Massimo Cristofanilli2, Beth Overmoyer3, Dan Rea4, Fedor Berdichevski4, Mohamad El-Shinawi5, Jennifer Bellon6, Huong T. Le-Petross1, Anthony Lucci1, Gildy Babiera1, Sarah M. DeSnyder1, Mediget Teshome1, Edward Chang1, Bora Lim1, Savitri Krishnamurthy1, Michael C Stauder1, Simrit Parmar6, Mona M Mohamed7, Angela Alexander1, Vicente Valero1, Wendy A. Woodward1✉

1. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
2. Department of Medicine, Division of Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, USA
3. Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
4. School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, UK
5. Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
6. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
7. Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
* Equal first authors.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 2018; 9(8):1437-1447. doi:10.7150/jca.23969. Available from http://www.jcancer.org/v09p1437.htm

File import instruction

Abstract

National and international experts in inflammatory breast cancer (IBC) from high-volume centers treating IBC recently convened at the 10th Anniversary Conference of the Morgan Welch Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management of patients with IBC was discussed, summarized, and subsequently reviewed. All participants at the conference (patients, advocates, researchers, trainees, and clinicians) were queried using the MDRing electronic survey on key management issues. A summary of the expert consensus and participant voting is presented. Bilateral breast and nodal evaluation, breast magnetic resonance imaging, positron emission tomography/computed tomography, and medical photographs were endorsed as optimal. Neoadjuvant systemic therapy, modified radical mastectomy and level I and II ipsilateral axillary node dissection, post-mastectomy radiotherapy, adjuvant targeted therapy and hormonal therapy as indicated, and delayed reconstruction were agreed-upon fundamental premises of standard non-protocol-based treatment for IBC. Consideration for local-regional therapy in de novo stage IV IBC was endorsed to provide local control whenever feasible. Variation across centers and special circumstances were discussed.

Keywords: inflammatory breast cancer, management, BCS, radiation, mastectomy, neoadjuvant chemotherapy.